A subset of patients with MSS/MSI-low-colorectal cancer showed increased CD8(+) TILs together with up-regulated IFN-γ

A small subset of patients with proficient mismatch repair (pMMR)/microsatellite stable (MSS)-colorectal cancer (CRC) benefit from immunotherapy with anti-programmed cell death 1 (PD-1)/programmed death ligand 1 (PD-L1) blockade. Therefore, the aim of the current study was to evaluate the immune sta...

Descripción completa

Detalles Bibliográficos
Autores principales: Kikuchi, Tomohiro, Mimura, Kosaku, Okayama, Hirokazu, Nakayama, Yuko, Saito, Katsuharu, Yamada, Leo, Endo, Eisei, Sakamoto, Wataru, Fujita, Shotaro, Endo, Hisahito, Saito, Motonobu, Momma, Tomoyuki, Saze, Zenichiro, Ohki, Shinji, Kono, Koji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6865144/
https://www.ncbi.nlm.nih.gov/pubmed/31788072
http://dx.doi.org/10.3892/ol.2019.10953

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6865144/
https://www.ncbi.nlm.nih.gov/pubmed/31788072
http://dx.doi.org/10.3892/ol.2019.10953

Ejemplares similares